Hamburg, Sharfstein Nominations Shift Focus To Career FDAers’ Plans

Senior career FDA officials are viewing the selection of FDA Commissioner-nominee Margaret Hamburg with open minds. From the perspective of the core of FDA's drug regulatory activities, the staff view Hamburg's relative lack of experience as creating a clean slate